Marsh & McLennan (MRSH) Earnings Preview: Steady Growth Expected in Q3 2026
Key Takeaways
- Marsh & McLennan Companies (MRSH) — now operating under the "Marsh" brand — is scheduled to report third-quarter 2026 results before the market opens on Thursday, October 15, 2026.
- Wall Street consensus calls for adjusted earnings per share (EPS) of roughly $1.96, an increase of about 6% from $1.85 in the year-ago quarter.
- Analysts expect revenue near $6.6 billion, up approximately 4.5% from about $6.35 billion a year earlier.
- Marsh has beaten consensus EPS estimates in each of its last four quarters, most recently posting adjusted EPS of $2.96 in the second quarter of 2026.
- Investors will focus on underlying organic growth, insurance pricing trends, and progress on the company's "Thrive" cost-efficiency program.
Why This Report Matters
Marsh & McLennan Companies stands as a global leader in risk, insurance, reinsurance, and consulting across 130 countries. Its quarterly results offer a useful window into the commercial insurance cycle and corporate demand for advisory work. The company approaches this release with some momentum behind it: adjusted EPS climbed 8% in the first quarter of 2026, and second-quarter figures again came in ahead of expectations. The third-quarter update will show whether that pace can hold as insurance rate increases ease from earlier highs. For investors, it also provides an update on the three-year "Thrive" initiative aimed at boosting efficiency and margins.
What the Numbers Are Expected to Show
For the third quarter ended September 30, 2026, the consensus points to adjusted EPS of about $1.96 versus $1.85 a year earlier, with individual forecasts mostly falling between $1.92 and $2.00. Revenue is modeled around $6.6 billion, reflecting roughly 4.5% year-over-year growth.
Those headline numbers only tell part of the story. Marsh typically releases both GAAP results and adjusted figures that exclude items like restructuring costs and amortization of acquired intangibles. Investors pay close attention to organic revenue growth, which removes the impact of acquisitions and currency moves to highlight core business performance.
Two main segments drive the results: Risk & Insurance Services and Consulting. In the first quarter of 2026, Risk & Insurance Services revenue rose 6% while Consulting advanced 11%, supported by demand for actuarial, health, wealth, and management consulting services. Management has emphasized "underlying revenue growth" as its key metric, and the market will want to see that figure remain in the mid-single-digit range.
Marsh’s recent track record supports some optimism. The company has topped consensus EPS estimates in each of the past four quarters, with an average surprise of about 3% to 4%. Its latest report on July 21, 2026, delivered adjusted EPS of $2.96, ahead of the roughly $2.88 to $2.90 expected.
I also checked this using Tickeron’s AI Screener to compare the stock with peers in the sector.
Market Sentiment Heading Into the Print
Investor sentiment ahead of the third-quarter report appears mixed. Shares have lagged this year amid concerns that cooling commercial insurance pricing and a softer economic backdrop could slow growth. Marsh is not the only one facing these headwinds; the broader insurance-brokerage group has also faced pressure in 2026.
History shows that beating estimates does not always translate into a positive stock reaction. After strong third-quarter 2025 results, shares dropped sharply in pre-market trading as investors focused on declining insurance rates and broader economic uncertainty. This pattern highlights a potential risk: even an earnings beat could be overshadowed by cautious commentary on pricing or the demand outlook. With shares trading well below their 52-week high, investors will look to see whether results and guidance can shift the narrative toward more durable growth.
What to Watch Going Forward
Beyond the October 15 release, several themes will influence how investors assess Marsh for the rest of 2026 and into 2027.
First is the path of insurance pricing. As rate increases moderate across many commercial lines, the company will need to show that volume growth, client retention, and cross-selling can keep revenue moving. Commentary on property, casualty, and specialty lines will draw particular attention.
Second, the "Thrive" program remains a key focus. Management has targeted meaningful cost savings over three years, and investors will seek evidence that efficiency gains are flowing through to adjusted operating margin expansion without cutting back on growth investments.
Third, mergers and acquisitions continue to serve as a growth tool. Recent and planned deals, including the McGriff insurance-services acquisition and the AltamarCAM expansion into private asset management, will be watched for integration progress and their contribution to results.
Finally, capital allocation remains relevant. Strong free cash flow has backed dividend increases and share buybacks, so any update on the pace of repurchases or deleveraging will be closely examined. For the full year 2026, analysts currently model adjusted EPS of roughly $10.44 on revenue near $28.6 billion, expectations that depend on a solid finish to the year.
Using AI Tools in My Research
In my regular analysis of earnings setups like this one, I often rely on Tickeron’s AI Screener to quickly filter for sector trends, comparable names, and technical signals. It helps surface context around organic growth patterns and valuation without spending hours on manual screens, which keeps my focus on the key drivers for Marsh ahead of the report.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MRSH's RSI Indicator climbs out of oversold territory
The RSI Indicator for MRSH moved out of oversold territory on September 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 17 of the 28 cases the stock moved higher. This puts the odds of a move higher at 61%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on MRSH as a result. In 45 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.
The Moving Average Convergence Divergence (MACD) for MRSH just turned positive on October 02, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in 26 of 51 cases over the following month. The odds of a continued upward trend are 51%.
Following a +2.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 164 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
MRSH moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRSH crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
MRSH broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MRSH entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.313) is normal, around the industry mean (6.334). P/E Ratio (20.639) is within average values for comparable stocks, (32.709). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.022) settles around the average of (0.010) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (2.968).
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InsuranceBrokersServices
Advertisement